Source link : https://www.newshealth.biz/health-news/il-31-drug-for-itchy-nodular-skin-disease-gets-thumbs-up-from-fda/
The FDA approved the interleukin (IL)-31 monoclonal antibody nemolizumab (Nemluvio) for treating prurigo nodularis, drugmaker Galderma announced on Tuesday. The approval stipulates use in adults with prurigo nodularis, a skin condition characterized by chronic itch, nodules covering large areas of the body, and poor sleep quality. Driven by IL-31 signaling, involved in itch, inflammation, and […]
Author : News Health
Publish date : 2024-08-13 16:43:29
Copyright for syndicated content belongs to the linked Source.